SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alnylam Pharmaceuticals, Inc. (ALNY) -- Ignore unavailable to you. Want to Upgrade?


To: kenhott who wrote (114)7/10/2007 2:07:14 PM
From: BulbaMan  Read Replies (1) | Respond to of 166
 
Ken: Tekmira has about 25 million shares out (maybe 27 million diluted). So at C$1.65, you get a market cap of about C$45 million diluted. They have about C$25 million in cash, so their IP & partnerships are valued at only about C$20 million. See their website for more info: inexpharm.com